Stem cell firm Regeneus raising targets $10m – The Australian
|
Stem cell firm Regeneus raising targets $10m
The Australian REGENEUS executive chairman John Martin blanches at suggestions the regenerative medicine minnow is a poor man's alternative to stem–cell play Mesoblast, which commands a $1.9 billion market valuation. “We are not a poor man's anyone — we have … |
